Retrospective Cohort Study
Copyright ©The Author(s) 2024.
World J Diabetes. Jun 15, 2024; 15(6): 1212-1225
Published online Jun 15, 2024. doi: 10.4239/wjd.v15.i6.1212
Table 3 Partial correlation analysis between cystatin C, retinol-binding protein-4, U-α2- macroglobulin, U-podocalyxin, U-α-L-fucosidase, and clinical indicators
IndicatorCysC

RBP-4

U-α2-MG/UCr

U-PCX/UCr

U-AFU/UCr

r
P value
r
P value
r
P value
r
P value
r
P value
UACR0.730< 0.0010.625< 0.0010.805< 0.0010.639< 0.0010.780< 0.001
eGFR-0.816< 0.001-0.702< 0.001-0.711< 0.001-0.604< 0.001-0.742< 0.001
CysC1.000-0.693< 0.0010.710< 0.0010.645< 0.0010.692< 0.001
RBP-40.693< 0.0011.000-0.530< 0.0010.432< 0.0010.588< 0.001
U-α2-MG/UCr0.710< 0.0010.530< 0.0011.000-0.820< 0.0010.874< 0.001
U-PCX/UCr0.645< 0.0010.432< 0.0010.820< 0.0011.000-0.746< 0.001
U-AFU/UCr0.692< 0.0010.588< 0.0010.874< 0.0010.746< 0.0011.000-
Scr0.953< 0.0010.680< 0.0010.755< 0.0010.645< 0.0010.715< 0.001
Urea0.799< 0.0010.651< 0.0010.657< 0.0010.568< 0.0010.703< 0.001
UTP/24 h0.665< 0.0010.506< 0.0010.740< 0.0010.523< 0.0010.743< 0.001
NLR0.417< 0.0010.1670.0180.311< 0.0010.299< 0.0010.313< 0.001
hs-CRP0.0670.3430.0790.2670.0940.1860.1110.1180.0870.222